Mwanzo2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$ 13.42
Bei za siku
$ 13.42 - $ 13.68
Bei za mwaka
$ 11.32 - $ 21.25
Thamani ya kampuni katika soko
59.49B HKD
Wastani wa hisa zilizouzwa
6.80M
Uwiano wa bei na mapato
14.05
Mgao wa faida
2.21%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 10.16B | -6.56% |
Matumizi ya uendeshaji wa biashara | 4.10B | -8.74% |
Mapato halisi | 609.73M | -38.22% |
Kiwango cha faida halisi | 6.00 | -33.92% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.64B | 1.81% |
Asilimia ya kodi ya mapato | 22.80% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.02B | -6.45% |
Jumla ya mali | 113.75B | 5.93% |
Jumla ya dhima | 56.21B | 7.41% |
Jumla ya hisa | 57.54B | — |
hisa zilizosalia | 2.67B | — |
Uwiano wa bei na thamani | 0.77 | — |
Faida inayotokana na mali | 2.16% | — |
Faida inayotokana mtaji | 2.66% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 609.73M | -38.22% |
Pesa kutokana na shughuli | 917.31M | 5.05% |
Pesa kutokana na uwekezaji | -1.19B | -768.33% |
Pesa kutokana na ufadhili | 98.64M | -65.02% |
Mabadiliko halisi ya pesa taslimu | -151.74M | -115.96% |
Mtiririko huru wa pesa | -1.85B | 45.37% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,370